Henry Schein, Inc. (0L3C.L) Financials
0L3C.L Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 27, 2025 | 11.2 billion | 6.4 billion |
| Sept. 27, 2025 | 11.1 billion | 6.2 billion |
| June 28, 2025 | 10.9 billion | 6.0 billion |
| March 29, 2025 | 10.5 billion | 5.8 billion |
0L3C.L Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 27, 2025 | 338.0 million | ? |
| Sept. 27, 2025 | 141.0 million | 13.0 million |
| June 28, 2025 | 88.0 million | 11.0 million |
| March 29, 2025 | -6.0 million | 5.0 million |
0L3C.L Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| Dec. 27, 2025 | 101.0 million |
| Sept. 27, 2025 | 109.0 million |
| June 28, 2025 | 94.0 million |
| March 29, 2025 | 113.0 million |
0L3C.L Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 27, 2025 | 156.0 million | 2.8 billion | 251.0 million |
| Sept. 27, 2025 | 136.0 million | 2.4 billion | 264.0 million |
| June 28, 2025 | 145.0 million | 2.3 billion | 340.0 million |
| March 29, 2025 | 127.0 million | 2.2 billion | 333.0 million |
0L3C.L Shares Outstanding
0L3C.L Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 27, 2025 | 43.0 million | - | 808.0 million | - |
| Sept. 27, 2025 | 33.0 million | - | 752.0 million | - |
| June 28, 2025 | 32.0 million | - | 777.0 million | - |
| March 29, 2025 | 43.0 million | - | 736.0 million | - |
0L3C.L Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 27, 2025 | 3.4 billion | 2.4 billion |
| Sept. 27, 2025 | 3.3 billion | 2.4 billion |
| June 28, 2025 | 3.2 billion | 2.3 billion |
| March 29, 2025 | 3.2 billion | 2.2 billion |
0L3C.L
Price: $76.97
52 week price:
Payout Ratio Range:
Earnings Per Share: 4.59 USD
P/E Ratio: 17.41
Exchange: LSE
Sector: Healthcare
Industry: Medical - Equipment & Services
Market Capitalization: 9.6 billion